Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Posted on by ScienceFather

Prof. Dr. Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Prof. Dr. Nurşen Sarı, GAZI UNIVERSITY, Turkey

Prof. Dr. Nurşen Sarı is a distinguished academic in Inorganic Chemistry with a focus on Polymeric Complexes, Bioinorganic Chemistry, and Transition Metals. She has authored 63 articles in SCI/SCI-Expanded journals and over 200 conference proceedings. Prof. Sarı has supervised 17 graduate theses and taught various courses such as Supramolecular Chemistry and Metallurgical Chemistry at Gazi University, where she served as Vice Chair and Erasmus Coordinator. She is passionate about chemistry, seeing it as the key to understanding life. 🌍🔬📚

Publication Profile

Orcid

Google Scholar

Academic and Administrative Leadership

Prof. Dr. Nurşen Sarı has held key academic and administrative roles at Gazi University. She served as a Board Member at the Institute of Science and Technology (2018-2021) and as Vice Chair of the Department of Chemistry (2013-2020). She led the Chemistry Community as Academic Leader (2016-2019) and coordinated the Erasmus Program for the department (2013-2016). Additionally, Prof. Sarı was the Farabi Department Coordinator (2013-2016). Her leadership has significantly shaped the university’s academic direction. 📚🌍🎓👩‍🏫

 

Research Areas

Prof. Dr. Nurşen Sarı’s research spans diverse areas of Inorganic Chemistry and Bioinorganic Chemistry, focusing on Polymeric Complexes, Transition Metals, and Inorganic Polymers. Her work explores the structure and behavior of Inorganic Ring Compounds, Coordination Chemistry, and the mechanisms and kinetics of inorganic reactions. Prof. Sarı’s research contributes significantly to the understanding of the interactions between metals and organic ligands, which has applications in various scientific fields. Her passion for Natural Sciences drives her to uncover new insights into the molecular world. 🌐🔬🧪🧬

 

Research Focus

Prof. Dr. Nurşen Sarı’s research focuses on several key areas within Inorganic and Bioinorganic Chemistry. Her work includes the synthesis and biological activities of polymeric complexes, Schiff bases, and their transition metal complexes, exploring their antimicrobial and antifungal properties. She also investigates coordination chemistry, inorganic polymers, and reaction mechanisms. Her studies contribute to the development of new materials with applications in biosensors, antimicrobial agents, and medical diagnostics. These endeavors have led to significant publications in prestigious journals. 🧪🔬⚗️🌍🧫

 

Publication Top Notes  

🔍 Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid (glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese (III) complexes
Cited by: 195
Year: 2004

🔍 ANTIBACTERIAL ACTIVITES OF SOME NEW AMINO ACID-SCHI BASES
Cited by: 160
Year: 2003

🔍 Synthesis and biological activity of new cycloalkylthiophene-Schiff bases and their Cr (III) and Zn (II) complexes
Cited by: 57
Year: 2010

🔍 Synthesis, potentiometric and antimicrobial activity studies on 2-pyridinilidene-DL-amino acids and their complexes
Cited by: 55
Year: 2003

🔍 Structural, electrochemical and optical properties of hydrothermally synthesized transition metal oxide (Co3O4, NiO, CuO) nanoflowers
Cited by: 46
Year: 2020

🔍 Synthesis of Some Polymer‐Metal Complexes and Elucidation of their Structures
Cited by: 46
Year: 2006

🔍 Spectroscopic characterization of novel d-amino acid-Schiff bases and their Cr(III) and Ni(II) complexes as antimicrobial agents
Cited by: 37
Year: 2013

🔍 Preparation of carbon paste electrodes including poly (styrene) attached glycine–Pt (IV) for amperometric detection of glucose
Cited by: 34
Year: 2014

🔍 Nanospheres caped Pt (II) and Pt (IV): synthesis and evaluation as antimicrobial and Antifungal Agent
Cited by: 31
Year: 2017

🔍 Ni (II)-tetrahedral complexes: Characterization, antimicrobial properties, theoretical studies and a new family of charge-transfer transitions
Cited by: 31
Year: 2013

🔍 Some novel amino acid-schiff bases and their complexes synthesis, characterization, solid state conductivity behaviors and potentiometric studies
Cited by: 29
Year: 2004

🔍 Synthesis, antimicrobial and antimutagenic effects of novel polymeric-Schiff bases including indol
Cited by: 27
Year: 2019

🔍 Polystyrene attached Pt (IV)–azomethine, synthesis and immobilization of glucose oxidase enzyme
Cited by: 27
Year: 2012

🔍 Synthesis, potentiometric and antimicrobial activity studies on DL-amino acids-Schiff bases and their complexes
Cited by: 27

 

Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Posted on by ScienceFather

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background 🎓

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. 🎓📚🔬

 

Professional Experience 🧑‍🔬

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience 📚👨‍🏫

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions 🏆🎖️

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). 🏅📚

 

Research Focus

 

Dr. Victor Chigozie’s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. 🌱💊

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace – D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Al‐Ouqaili, … (Cited by: 405, Year: 2022) 🦠
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa – FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) 🌿
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca – V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) 🍌
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica – VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) 🥭
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti – GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) 🦟
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka – OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) 💊
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review – M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) 🏥
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria – VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) 💉
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) – LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) 🍵
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … – DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) 🍃

Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. 🧪📚

Publication profile

Google Scholar

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. 📚🔬

 

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. 🌟🎓

 

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. 🌟🔬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. 💼✨

 

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. 🌱💊

 

Publication Top Notes  

 

  • Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 📄
  • Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 💊
  • Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
  • Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
  • Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
  • Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 💊
  • Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 📊
  • Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 🔍
  • UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 💡
  • Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
  • A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 ✔️
  • Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚡
  • Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 📈
  • UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 📊
  • Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 💼